Nephrogenic systemic fibrosis - PDFSEARCH.IO - Document Search Engine

Nephrogenic systemic fibrosis
Results: 47

#	Item
31	ONC-2R-OSLO WARING: NEPHROGENIC SYSTEMIC FIBROSIS Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with: . acute or chronic severe renal insufficiency Cglomerular fi Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:43:12 Gadolinium Gadopentetic acid Nephrogenic systemic fibrosis Magnetic resonance imaging MRI contrast agent Chemistry Matter Gadodiamide
32	ProHance(8 Multipack™ (Gadoteridol) Injection, 279.3 mg/mL Pharmacy Bulk Package -...Page 1 of9 Prohance Multipack (gadoteridol) Injection, Solution (Bracco Diagnostics Inc. i Pharmacy Bulk Package - Not for Direct I Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:43:14 Gadodiamide Nephrogenic systemic fibrosis Gadopentetic acid Gadoteridol Gadolinium Magnetic resonance imaging Aspirin MRI contrast agent Chemistry Matter Medicine
33	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Gadodiamide Gadopentetic acid Nephrogenic systemic fibrosis Magnetic resonance imaging Chronic kidney disease Food and Drug Administration Jonathan L. Halperin MRI contrast agent Chemistry Medicine Matter
34	MAGNEVIST® (brand of gadopentetate dimeglumine) Injection Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-10-18 16:38:56 Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Pentetic acid MRI contrast agent Gadodiamide Chemistry Matter Gadopentetic acid
35	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Gadopentetic acid Gadodiamide Nephrogenic systemic fibrosis Magnetic resonance imaging Food and Drug Administration Bayer Gadobenic acid Epidemiology Chemistry Medicine Matter
36	MAGNEVIST (( (brand of gadopentetate dimeglumine[removed]Injection Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:42:48 Gadolinium Gadodiamide Magnetic resonance imaging Nephrogenic systemic fibrosis Pentetic acid Functional magnetic resonance imaging MRI contrast agent Chemistry Matter Gadopentetic acid
37	GE Healthcare 101 Carnegie Center Princeton, New Jersey[removed]USA June 6, 2006 Add to Reading List Source URL: www.fda.gov Language: English Nephrogenic systemic fibrosis Nephrology Gadodiamide MRI contrast agent Gadolinium Magnetic resonance imaging General Electric Contrast medium Chemistry Matter Medicine
38	multihanceCI(gadobenate dimeglumine) injection, 529 mg/mL Page 1 of 12 Multihance (gadobenate dimeglumine) Injection, Solution (Bracco Diagnostics Inc.) Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:45:44 Gadodiamide Gadopentetic acid Nephrogenic systemic fibrosis Magnetic resonance imaging MRI contrast agent Chemistry Matter Gadolinium
39	May[removed]OptiMARK~ (gadoversetamide injection) For Intravenous Injection Only Mallinckrodt Inc. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:44:40 MRI contrast agent Nephrogenic systemic fibrosis Gadolinium Gadodiamide Gadopentetic acid Magnetic resonance imaging Gadoversetamide Chemistry Matter Medicine
40	MultihanceQ! (gadobenate dimeglumine) injection, 529 mg/mL NEPHROGENIC SYSTEMIC FIBROSIS Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-10-14 17:39:38 Gadodiamide Magnetic resonance imaging Gadopentetic acid Nephrogenic systemic fibrosis MRI contrast agent Chemistry Matter Gadolinium

UPDATE